FOLFIRINOX is an acronym for a group of chemotherapeutic schemes approved in oncology and used for treating pancreatic cancer.
The classical FOLFIRINOX scheme consists of:
This scheme appeared in 2010 as a new treatment method for patients with metastatic pancreatic cancer. One study published in the New England Journal of Medicine showed that the FOLFIRINOX regimen demonstrated the most significant increase in survival rate among patients with advanced stages of pancreatic cancer (among all Phase III clinical trials studying this pathology). Patients who got FOLFIRINOX regimen lived on average 4 months longer than patients with standard monotherapy with Gemcitabine (11.1 months in comparison with 6.8 months).
To achieve the best results in cancer treatment, Onco.Rehab clinic employs a variety of effective strategies, including FOLFIRINOX, which is also used in conjunction with curcumin.
To get a consultation/hospitalization in OOO “Onkoklinika” you should go to the clinic residence (oncology clinic) at the place of your and take a reference (057-U) with the signature of your treating doctor and the seal of the medical organization.
The manager contacts patients just after the concilium of doctors (every Thursday) where the specialists look through all the documents and make a decision about the necessary treatment.